Growth Metrics

Armata Pharmaceuticals (ARMP) Other Non-Current Liabilities (2016 - 2019)

Quarterly results put Other Non-Current Liabilities at $1.3 million for Q4 2019, up 20.59% from a year ago — trailing twelve months through Dec 2019 was $1.3 million (up 20.59% YoY), and the annual figure for FY2019 was $1.3 million, up 20.59%.

Armata Pharmaceuticals has reported Other Non-Current Liabilities over the past 7 years, most recently at $1.3 million for Q4 2019.

  • Other Non-Current Liabilities reached $1.3 million in Q4 2019 per ARMP's latest filing, up from $1.2 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $14.7 million in Q1 2015 and bottomed at $2000.0 in Q1 2016.
  • Median Other Non-Current Liabilities over the past 5 years was $1.2 million (2019), compared with a mean of $1.8 million.
  • The largest annual shift saw Other Non-Current Liabilities tumbled 99.99% in 2016 before it skyrocketed 116350.0% in 2017.
  • Over 5 years, Other Non-Current Liabilities stood at $1.5 million in 2015, then surged by 62.98% to $2.4 million in 2016, then tumbled by 88.05% to $292000.0 in 2017, then surged by 282.53% to $1.1 million in 2018, then grew by 20.59% to $1.3 million in 2019.
  • Business Quant data shows Other Non-Current Liabilities for ARMP at $1.3 million in Q4 2019, $1.2 million in Q3 2019, and $1.2 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2019 1.35 Mn
Sep 30, 2019 1.23 Mn
Mar 31, 2019 1.16 Mn
Dec 31, 2018 1.12 Mn
Sep 30, 2018 154,000.00
Jun 30, 2018 185,000.00
Mar 31, 2018 187,000.00
Dec 31, 2017 292,000.00
Sep 30, 2017 400,000.00
Jun 30, 2017 387,000.00
Mar 31, 2017 2.33 Mn
Dec 31, 2016 2.44 Mn
Sep 30, 2016 1.65 Mn
Jun 30, 2016 1.47 Mn